Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)
Zeuzem, S., Flisiak, R., Vierling, J. M., Mazur, W., Mazzella, G., Thongsawat, S., Abdurakhmanov, D., Van Kính, N., Calistru, P., Heo, J., Stanciu, C., Gould, M., Makara, M., Hsu, S.-J., Buggisch, P.,Volume:
42
Language:
english
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.13342
Date:
October, 2015
File:
PDF, 841 KB
english, 2015